Savvy Updates, 12/16/19: FDA Approves Tandem Control-IQ, On Dexcom’s Outage, Pacific Diabetes Tech CGM/Infusion Set, Sanofi Exits Diabetes Biz, CGMs 2020, T1 Females at Higher Heart Risk, Abbott Libre Limits Data Access, Gifts for Medical Professionals?
FDA OKs Tandem Diabetes Control-IQ! was reported by Mike Hoskins for DiabetesMine.com, 13 December 2019. Control-IQ combines Tandem’s touchscreen insulin pump with the popular Dexcom CGM (continuous glucose monitor) and a smart algorithm that not only...
Savvy Pets, 12/13/19: A House Full of Fur: Enzo, Erni and Miles Davis
AWWWWWW! I mean, REALLY, AWWWWWWWWWWWWWWWWWWWWWW! Please meet Enzo (Furrari), Erni (Ernesto Meowserati) and Miles Davis, who live with humans, Christopher (T1 and Tidepool Community Manager) and Dayle. I’ve been following these 3 on Instagram...
Savvy Health, 12/11/19: Insulin Resistance, BPA as an Endocrine Disruptor, Banana Art
Insulin resistance, fasting, and low carbohydrate diets — how it works – Exploring what insulin resistance is, and why common remedies like fasting and ketogenic diets seem to work so well – was written by Philip Marais for Medium/Health, 30 October...
Breaking News, 12/10/19: Beta Bionics Receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System
BOSTON, Dec. 10, 2019 (GLOBE NEWSWIRE) — Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas — today announced it has received Breakthrough Device designation from the U.S....
More Diabetes Blogs